Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Total Non-Current Liabilities (2016 - 2021)

CorMedix's Total Non-Current Liabilities history spans 5 years, with the latest figure at $5.8 million for Q4 2021.

  • For Q4 2021, Total Non-Current Liabilities changed N/A year-over-year to $5.8 million; the TTM value through Dec 2021 reached $5.8 million, changed N/A, while the annual FY2021 figure was $5.8 million, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q4 2021 was $5.8 million at CorMedix, up from $3.9 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $5.8 million in Q4 2021 and bottomed at $3.9 million in Q2 2017.